A novel animal model for bone metastasis in human lung cancer

Oncology Letters

Volumn 3, Issue 4, 2012, Pages 802-806

  Li, Mi ^a   Zhou, Mingliang ^a   Gong, Meng ^a,b   Ma, Junrong ^a,b   Pei, Fuxing ^a   Beamer, Wesley G ^c   Shultz, Leonard D ^c   Hock, Janet M ^b   Yu, Xijie ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b Maine Institute for Human Genetics & Health   (United States)

^c JACKSON LABORATORY   (United States)

Author keywords

Animal model; Bone metastasis; Lung cancer

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; B LYMPHOCYTE; BONE METASTASIS; CANCER CELL CULTURE; EXPERIMENTAL MODEL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY; LIVER; LUNG CANCER; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; OVARY; PANCREAS; SPLEEN; T LYMPHOCYTE; TISSUE DISTRIBUTION; TUMOR XENOGRAFT; UTERUS; X RAY FILM;

EID: 84863143276     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.586     Document Type: Article

References (31)

1. Quint LE, Francis IR, Wahl RL and BH G: Imaging of lung cancer. In: Lung Cancer, Principles and Practice. Lippincott-Raven, Philadelphia, pp 775-789, 1996.
2. Mundy GR: Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2: 584-593, 2002.
3. Mantyh PW: Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci 7: 797-809, 2006.
4. Rubens RD: The nature of metastatic bone disease. In: Bone Metastases: Diagnosis and Treatment. Rubens RD, Fogelman I (eds.). Springer-Verlag, New York, pp 1-9, 1991.
5. Diel IJ, Solomayer EF and Bastert G: Treatment of metastatic bone disease in breast cancer: bisphosphonates. Clin Breast Cancer 1: 43-51, 2000.
6. Casimiro S, Guise TA and Chirgwin J: The critical role of the bone microenvironment in cancer metastases. Mol Cell Endocrinol 310: 71-81, 2009.
7. Roodman GD: Biology of osteoclast activation in cancer. J Clin Oncol 19: 3562-3571, 2001.
8. Reddi AH, Roodman D, Freeman C and Mohla S: Mechanisms of tumor metastasis to the bone: challenges and opportunities. J Bone Miner Res 18: 190-194, 2003.
9. Shultz LD, Ishikawa F and Greiner DL: Humanized mice in translational biomedical research. Nat Rev Immunol 7: 118-130, 2007.
10. Wu J and Lanier LL: Natural killer cells and cancer. Adv Cancer Res 90: 127-156, 2003.
11. Dewan MZ, Terunuma H, Ahmed S, et al: Natural killer cells in breast cancer cell growth and metastasis in SCID mice. Biomed Pharmacother 59 (Suppl 2): 375-379, 2005.
12. Quarmby S, Kumar P and Kumar S: Radiation-induced normal tissue injury: role of adhesion molecules in leukocyte-endothelial cell interactions. Int J Cancer 82: 385-395, 1999.
13. Fulop GM and Phillips RA: The scid mutation in mice causes a general defect in DNA repair. Nature 347: 479-482, 1990.
14. Lechler R, Ng WF and Steinman RM: Dendritic cells in transplantation--friend or foe? Immunity 14: 357-368, 2001.
15. Yano S, Nishioka Y, Izumi K, et al: Novel metastasis model of human lung cancer in SCID mice depleted of NK cells. Int J Cancer 67: 211-217, 1996.
16. Yano S and Sone S: Novel metastasis model of human lung cancer cells representing different histological types in SCID mice depleted of NK cells. Gan To Kagaku Ryoho 24: 489-494, 1997.
17. Miki T, Yano S, Hanibuchi M and Sone S: Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice. Oncol Res 12: 209-217, 2000.
18. Bosma GC, Custer RP and Bosma MJ: A severe combined immunodeficiency mutation in the mouse. Nature 301: 527-530, 1983.
19. Yang W, Lam P, Kitching R, et al: Breast cancer metastasis in a human bone NOD/SCID mouse model. Cancer Biol Ther 6: 1289-1294, 2007.
20. Murthy MS, Scanlon EF, Jelachich ML, Klipstein S and Goldschmidt RA: Growth and metastasis of human breast cancers in athymic nude mice. Clin Exp Metastasis 13: 3-15, 1995.
21. Shultz LD, Schweitzer PA, Christianson SW, et al: Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 154: 180-191, 1995.
22. Shtivelman E and Namikawa R: Species-specific metastasis of human tumor cells in the severe combined immunodeficiency mouse engrafted with human tissue. Proc Natl Acad Sci USA 92: 4661-4665, 1995.
23. Nemeth JA, Harb JF, Barroso U Jr, He Z, Grignon DJ and Cher ML: Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res 59: 1987-1993, 1999.
24. Yonou H, Yokose T, Kamijo T, et al: Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone. Cancer Res 61: 2177-2182, 2001.
25. Kuperwasser C, Dessain S, Bierbaum BE, et al: A mouse model of human breast cancer metastasis to human bone. Cancer Res 65: 6130-6138, 2005.
26. Shankaran V, Ikeda H, Bruce AT, et al: IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410: 1107-1111, 2001.
27. Ito M, Hiramatsu H, Kobayashi K, et al: NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100: 3175-3182, 2002.
28. Sugamura K, Asao H, Kondo M, et al: The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu Rev Immunol 14: 179-205, 1996.
29. Cao X, Shores EW, Hu-Li J, et al: Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2: 223-238, 1995.
30. DiSanto JP, Muller W, Guy-Grand D, Fischer A and Rajewsky K: Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci USA 92: 377-381, 1995.
31. Ohbo K, Suda T, Hashiyama M, et al: Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain. Blood 87: 956-967, 1996.